Lupin | Zee News

Advertisement

Lupin News

Lupin Q4 income

15 May 2018

Lupin Q4 net loss at Rs 783 crore

The company had reported a net profit of Rs 380.21 crore for the same period of 2016-17.

BSE's benchmark index

17 Nov 2017

IndusInd Bank, Yes Bank to join BSE Sensex; Cipla, Lupin exit

The changes are announced by Asia Index, a joint venture between S&P Dow Jones Indices LLC and BSE. The move is a part of Asia Index's semi-annual reconstitution results.

Investore wealth

26 May 2017

Investor wealth surges over Rs 50 lakh crore in 3 years

Investor wealth has surged by over Rs 50 lakh crore since the Modi government was voted to power three years ago, with the Sensex surging to its lifetime high of 31,074.07 on Friday.

03 May 2017

Lupin extends losses, loses m-cap by Rs 3,315 crore in 2 days

Registering losses for the second day, Lupin on Wednesday fell by 3 percent on US health regulator's observations for its Goa plant.

02 Mar 2017

Pharma giant Lupin embarks on generic drug treatment to treat depression in US

We have launched generic Pristiq (Desvenlafaxine Succinate) extended-release tablets, 50 mg and 100 mg having received an approval from the United States Food and Drug Administration (FDA) earlier.

28 Feb 2017

Pharma major Lupin gets USFDA nod to market colonoscopy drugs, pain relief

The approved product is indicated for relief of moderate to moderately severe pain. Percocet tablets had US sales of USD 838.7 million.

26 Dec 2016

Lupin receives USFDA nod for hypertension treatment drug in US

Drug major Lupin has received tentative approval from the US health regulator to sell Olmesartan medoximil tablets, used for treating high blood pressure, in the American market.

27 Sep 2016

Brokerage view on the stocks of 'Lupin, Idea, JP Morgan etc

06 Sep 2016

Lupin gets USFDA tentative nod for anti-bacterial tablets

Drug firm Lupin has received tentative approval from the US health regulator to market its generic anti-bacterial moxifloxacin hydrochloride tablets in the American market.

TCS and Infosys

26 Jul 2016

TCS, Infosys in Forbes 'Super 50' list; Tata Motors, HUL dropped

Software majors TCS and Infosys, pharma giants Sun Pharma and Lupin and private sector lenders HDFC Bank and Axis Bank feature in Forbes India's Super 50 List this year, while biggies like Tata Motors and HUL have been dropped.

07 Jul 2016

USFDA clears Lupin's Goa facility; stocks up 6.25%

Pharma firm Lupin has received Establishment Inspection Report (EIR) from the US health regulator for its Goa facility regarding a inspection done by the USFDA in July last year.

Drug major Lupin

13 Jun 2016

Committed to close corrective action at Goa by Dec: Lupin

New Delhi: Drug major Lupin has committed to close the corrective action at its Goa facility, which had received nine observations from US health regulator, by December.

11 Apr 2016

Lupin to market Novartis' inhaler under Loftair brand name

Drug major Lupin and Novartis Healthcare have inked a co-marketing agreement under which Lupin will market Novartis' inhaler, used to treat chronic obstructive pulmonary disease, under the brand name Loftair in India

05 Apr 2016

Lupin launches generic insomnia drug in US

Drug major Lupin has launched a generic insomnia drug, Zolpidem Sublingual tablets, in the US market with 180-days of marketing exclusivity.

31 Mar 2016

Lupin launches generic Aricept tablets in US market

Drug major Lupin has launched Donepezil Hydrochloride tablets, used in treating Alzheimer's disease, in the US market after having received the US health regulator USFDA's nod for the product earlier

29 Mar 2016

Lupin shares hit 52-week low; tank over 14%

Shares of pharma firm Lupin today tumbled over 14 per cent to hit their one-year low level amid reports of regulatory concerns at one of its unit.

19 Mar 2016

10 best companies to work for in India

10 Indian companies made it to the list under the '25 Best Large Places to Work'

15 Mar 2016

Lupin receives nine observations from USFDA for Goa plant

Drug major Lupin on Tuesday says that it has received nine observations relating to inadequacy and adherence to operating norms for its manufacturing plant in Goa from the US Food and Drug Administration (USFDA)

05 Feb 2016

Expert view on Lupin stocks

05 Feb 2016

Lupin Q3 net profit dips 12% to Rs 530 crore

The company had posted a net profit of Rs 601.45 crore in the same period of the previous fiscal.

Loading...

NEWS ON ONE CLICK